| The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells J Mjösberg, J Bernink, K Golebski, JJ Karrich, CP Peters, B Blom, ... immunity 37 (4), 649-659, 2012 | 746 | 2012 |
| IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs SM Bal, JH Bernink, M Nagasawa, J Groot, MM Shikhagaie, K Golebski, ... Nature immunology 17 (6), 636-645, 2016 | 497 | 2016 |
| Plasticity of innate lymphoid cell subsets SM Bal, K Golebski, H Spits Nature Reviews Immunology 20 (9), 552-565, 2020 | 288 | 2020 |
| Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response K Golebski, JA Layhadi, U Sahiner, EH Steveling-Klein, MM Lenormand, ... Immunity 54 (2), 291-307. e7, 2021 | 209 | 2021 |
| IL-1β, IL-23, and TGF-β drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation K Golebski, XR Ros, M Nagasawa, S van Tol, BA Heesters, H Aglmous, ... Nature communications 10 (1), 2162, 2019 | 129 | 2019 |
| KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2− ILCs biased toward ILC2 or ILC3 M Nagasawa, BA Heesters, CMA Kradolfer, L Krabbendam, ... Journal of Experimental Medicine 216 (8), 1762-1776, 2019 | 118 | 2019 |
| Emerging roles of innate lymphoid cells in inflammatory diseases: clinical implications I Kortekaas Krohn, MM Shikhagaie, K Golebski, JH Bernink, C Breynaert, ... Allergy 73 (4), 837-850, 2018 | 105 | 2018 |
| New insights into the function, development, and plasticity of type 2 innate lymphoid cells L Krabbendam, SM Bal, H Spits, K Golebski Immunological reviews 286 (1), 74-85, 2018 | 93 | 2018 |
| Treating severe asthma: targeting the IL‐5 pathway S Principe, C Porsbjerg, S Bolm Ditlev, D Kjærsgaard Klein, K Golebski, ... Clinical & Experimental Allergy 51 (8), 992-1005, 2021 | 69 | 2021 |
| Ethylene production with engineered Synechocystis sp PCC 6803 strains VP Veetil, SA Angermayr, KJ Hellingwerf Microbial Cell Factories 16, 1-11, 2017 | 64 | 2017 |
| Anti-SARS-CoV-2 IgG from severely ill COVID-19 patients promotes macrophage hyper-inflammatory responses W Hoepel, HJ Chen, S Allahverdiyeva, X Manz, J Aman, ... BioRxiv, 2020.07. 13.190140, 2020 | 60 | 2020 |
| EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis PW Hellings, CA Akdis, C Bachert, J Bousquet, B Pugin, G Adriaensen, ... Rhinology 55 (3), 202-210, 2017 | 56 | 2017 |
| The multi‐faceted role of allergen exposure to the local airway mucosa K Golebski, KIL Röschmann, S Toppila‐Salmi, H Hammad, BN Lambrecht, ... Allergy 68 (2), 152-160, 2013 | 53 | 2013 |
| High degree of overlap between responses to a virus and to the house dust mite allergen in airway epithelial cells K Golebski, S Luiten, D van Egmond, E de Groot, KIL Röschmann, ... PloS one 9 (2), e87768, 2014 | 36 | 2014 |
| New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis I Striz, K Golebski, Z Strizova, S Loukides, P Bakakos, NA Hanania, ... Clinical Science 137 (9), 727-753, 2023 | 34 | 2023 |
| Innate lymphoid cells: the missing part of a puzzle in food allergy UM Sahiner, JA Layhadi, K Golebski, Z István Komlósi, Y Peng, B Sekerel, ... Allergy 76 (7), 2002-2016, 2021 | 33 | 2021 |
| Histone deacetylase inhibitors up-regulate LL-37 expression independent of toll-like receptor mediated signalling in airway epithelial cells Q Liu, J Liu, KIL Roschmann, D van Egmond, K Golebski, WJ Fokkens, ... Journal of Inflammation 10, 1-6, 2013 | 33 | 2013 |
| Specific induction of TSLP by the viral RNA analogue Poly (I: C) in primary epithelial cells derived from nasal polyps K Golebski, J van Tongeren, D van Egmond, EJ de Groot, WJ Fokkens, ... PloS one 11 (4), e0152808, 2016 | 31 | 2016 |
| Childhood asthma in the new omics era: challenges and perspectives K Golebski, M Kabesch, E Melén, U Potočnik, CM van Drunen, S Reinarts, ... Current opinion in allergy and clinical immunology 20 (2), 155-161, 2020 | 30 | 2020 |
| FcγRIII stimulation breaks the tolerance of human nasal epithelial cells to bacteria through cross-talk with TLR4 K Golebski, W Hoepel, D Van Egmond, EJ De Groot, GD Amatngalim, ... Mucosal immunology 12 (2), 425-433, 2019 | 24 | 2019 |